![Christopher Muller](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher Muller
Fondatore presso Mati Therapeutics, Inc.
Provenienza dei contatti di primo grado di Christopher Muller
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
QLT, Inc.
![]() QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada.
12
| Extinct | Miscellaneous Commercial Services | 12 |
Mati Therapeutics, Inc.
![]() Mati Therapeutics, Inc. BiotechnologyHealth Technology Mati Therapeutics, Inc. operates as biotechnology company. It develops non-invasive sustained drug delivery platform to treat ocular diseases, in particular glaucoma. The company was founded by Robert Lee Butchofsky and Christopher A. Muller and is headquartered in Austin, TX.
3
| Private Company | Biotechnology | 3 |
Advanced Medical Optics (AMO) GmbH
![]() Advanced Medical Optics (AMO) GmbH Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Advanced Medical Optics (AMO) GmbH is a Swiss company that develops and markets surgical eyewear. The company is based in Lachen, Switzerland. The CEO of the company is Max Lemme.
1
| Subsidiary | Medical Specialties | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Christopher Muller tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
TRAVERE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
CorMatrix Cardiovascular, Inc.
![]() CorMatrix Cardiovascular, Inc. Medical SpecialtiesHealth Technology CorMatrix Cardiovascular, Inc. develops and markets commercial medical devices. It offers CorMatrix CanGaroo, Vascular Repair, Pericardial Repair & Reconstruction, Tyke, and Cardiac Tissue Repair. The company was founded by David B. Camp and Robert G. Matheny in 2001 and is headquartered in Roswell, GA. | Medical Specialties | Director of Finance/CFO Director/Board Member | |
The University of Texas at Austin | College/University | Corporate Officer/Principal Undergraduate Degree | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
moksha8 Pharmaceuticals, Inc.
![]() moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director/Board Member | |
The University of Nottingham | College/University | Undergraduate Degree | |
Renovis, Inc.
![]() Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Pharmaceuticals: Major | Director/Board Member | |
DR. REDDY'S LABORATORIES LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Queen Elizabeth College | College/University | Doctorate Degree | |
XENCOR, INC. | Biotechnology | Chairman | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Global Alliance for TB Drug Development
![]() Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Pharmaceuticals: Generic | Chairman | |
REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member | |
ENANTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
Biothera, Inc.
![]() Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | Miscellaneous Commercial Services | Director/Board Member | |
Infectious Disease Research Institute
![]() Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Chairman | |
IMMUNE DESIGN CORP | Pharmaceuticals: Major | Director/Board Member | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal | |
VAXART, INC. | Biotechnology | Director/Board Member | |
BIOTA HOLDINGS LTD. | Pharmaceuticals: Major | Director/Board Member | |
Lakewood-Amedex, Inc.
![]() Lakewood-Amedex, Inc. Pharmaceuticals: MajorHealth Technology Lakewood-Amedex, Inc. engages in the development of treatment for serious infectious diseases. Its product pipeline include Nu-3 cDFU, Nu-3 Oral Mucositis, Nu-8 cUTI, and Nu-8 (Cystic Fibrosis). The company is headquartered in Sarasota, FL. | Pharmaceuticals: Major | Director/Board Member | |
Aronex Pharmaceuticals, Inc.
![]() Aronex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aronex Pharmaceuticals, Inc. develops proprietary medicines to treat cancer and infectious diseases. The company's products include Nyotran, Atragen, Annamycin, and Zintevir. It is headquartered in The Woodlands, TX. | Pharmaceuticals: Major | Chief Executive Officer | |
NovaDigm Therapeutics, Inc.
![]() NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND. | Pharmaceuticals: Major | Director/Board Member | |
ALDEYRA THERAPEUTICS, INC. | Biotechnology | Chairman | |
Takeda Vaccines (Montana), Inc.
![]() Takeda Vaccines (Montana), Inc. Pharmaceuticals: MajorHealth Technology Takeda Vaccines (Montana), Inc. operates as a biopharmaceutical company which focuses on the development of vaccines that prevent human infectious diseases. It specializes in developing vaccines against norovirus, influenza, and respiratory syncytial virus. The firm develops norovirus VLP vaccines that mimic the surface configuration of the live virus without the ability to cause infection, respiratory syncytial virus vaccine that mediates cell entry in its native form for use in anthrax treatment. The company was founded by Robert F. Bargatze on March 13, 2008 and is headquartered in Bozeman, MT. | Pharmaceuticals: Major | Chairman | |
FluGen, Inc.
![]() FluGen, Inc. Pharmaceuticals: MajorHealth Technology Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI. | Pharmaceuticals: Major | Chairman | |
REVO BIOLOGICS INC | Biotechnology | Chief Executive Officer | |
Massachusetts Biotechnology Council
![]() Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Director/Board Member | |
Koninklijke Gist Brocades NV
![]() Koninklijke Gist Brocades NV Pharmaceuticals: OtherHealth Technology Part of DSM-Firmenich AG, Koninklijke Gist Brocades NV is a Dutch company that manufactures and markets biotechnological products. The private company is based in Delft, the Netherlands. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Beacon Street Advisors LLC
![]() Beacon Street Advisors LLC Miscellaneous Commercial ServicesCommercial Services Beacon Street Advisors LLC provides financial services. The company is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of East Anglia | College/University | Doctorate Degree | |
University of Birmingham | College/University | Undergraduate Degree | |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Patheon Biologics LLC
![]() Patheon Biologics LLC BiotechnologyHealth Technology Patheon Biologics LLC manufactures, supplies clinical and commercial bulk biologics to the biopharmaceutical industry. The company was founded in 2010 and is headquartered in Jefferson City, MO. | Biotechnology | Director/Board Member | |
Red Sky Partners LLC | Corporate Officer/Principal | ||
AlphaVax, Inc.
![]() AlphaVax, Inc. Pharmaceuticals: MajorHealth Technology AlphaVax, Inc. involves in clinical-stage biopharmaceutical company. It develops vaccine technology bio products. The firm products include Alphavax and pipleline bio products. It focuses on commercial potential of its alphavaccine vector technology in cancer immunotherapy. The company was founded in 1997 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chairman | |
Aurigene Discovery Technologies Ltd.
![]() Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. | Biotechnology | Director/Board Member | |
MIRATI THERAPEUTICS | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 39 |
Regno Unito | 6 |
India | 3 |
Canada | 2 |
Israele | 2 |
Settori
Health Technology | 36 |
Consumer Services | 7 |
Commercial Services | 7 |
Process Industries | 2 |
Finance | 2 |
Posizioni
Director/Board Member | 116 |
Independent Dir/Board Member | 49 |
Chairman | 30 |
Director of Finance/CFO | 30 |
Corporate Officer/Principal | 22 |
Contatti più connessi
Insiders | |
---|---|
John Thomas | 30 |
Kathryn Falberg | 30 |
Bruce Carter | 25 |
John Kozarich | 21 |
Geoffrey F. Cox | 20 |
Jason Aryeh | 18 |
Vicente J. Anido | 16 |
Jeffrey Meckler | 15 |
C. Boyd Clarke | 15 |
Stephen Sabba | 9 |
Ian John Massey | 9 |
Robert Lee Butchofsky | 5 |
Cameron R. Nelson | 4 |
Deepank Utkhede | 2 |
Max Lemme | 1 |
- Borsa valori
- Insiders
- Christopher Muller
- Connessioni Società